1. Home
  2. SNY vs HOOD Comparison

SNY vs HOOD Comparison

Compare SNY & HOOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNY
  • HOOD
  • Stock Information
  • Founded
  • SNY 1994
  • HOOD 2013
  • Country
  • SNY France
  • HOOD United States
  • Employees
  • SNY N/A
  • HOOD N/A
  • Industry
  • SNY Biotechnology: Pharmaceutical Preparations
  • HOOD Computer Software: Prepackaged Software
  • Sector
  • SNY Health Care
  • HOOD Technology
  • Exchange
  • SNY Nasdaq
  • HOOD Nasdaq
  • Market Cap
  • SNY 116.1B
  • HOOD 127.2B
  • IPO Year
  • SNY N/A
  • HOOD 2021
  • Fundamental
  • Price
  • SNY $52.02
  • HOOD $118.56
  • Analyst Decision
  • SNY Buy
  • HOOD Buy
  • Analyst Count
  • SNY 4
  • HOOD 23
  • Target Price
  • SNY $61.50
  • HOOD $119.62
  • AVG Volume (30 Days)
  • SNY 2.3M
  • HOOD 27.3M
  • Earning Date
  • SNY 10-24-2025
  • HOOD 11-05-2025
  • Dividend Yield
  • SNY 3.07%
  • HOOD N/A
  • EPS Growth
  • SNY 105.93
  • HOOD 304.26
  • EPS
  • SNY 8.67
  • HOOD 2.39
  • Revenue
  • SNY $53,890,648,839.00
  • HOOD $4,204,000,000.00
  • Revenue This Year
  • SNY $2.37
  • HOOD $46.90
  • Revenue Next Year
  • SNY $6.51
  • HOOD $20.90
  • P/E Ratio
  • SNY $11.84
  • HOOD $51.24
  • Revenue Growth
  • SNY N/A
  • HOOD 74.58
  • 52 Week Low
  • SNY $44.62
  • HOOD $29.66
  • 52 Week High
  • SNY $60.12
  • HOOD $153.86
  • Technical
  • Relative Strength Index (RSI)
  • SNY 63.05
  • HOOD 40.34
  • Support Level
  • SNY $48.55
  • HOOD $114.00
  • Resistance Level
  • SNY $52.68
  • HOOD $138.99
  • Average True Range (ATR)
  • SNY 0.68
  • HOOD 7.87
  • MACD
  • SNY 0.15
  • HOOD -2.66
  • Stochastic Oscillator
  • SNY 84.28
  • HOOD 15.17

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

About HOOD Robinhood Markets Inc.

Robinhood Markets Inc is creating a modern financial services platform. It designs its own products and services and delivers them through a single, app-based cloud platform supported by proprietary technology. Its vertically integrated platform has enabled the introduction of new products and services such as cryptocurrency trading, dividend reinvestment, fraud detection, derivatives, fractional shares, recurring investments, and others.

Share on Social Networks: